Dr. Karen J Morgan-vanderlick, M.D. Anesthesiology - Pain Medicine Medicare: Accepting Medicare Assignments Practice Location: 1916w C St, Jenks, OK 74037 Phone: 918-701-2055 Fax: 918-701-2056 |
News Archive
McMaster researchers have developed a novel new gel made entirely from bacteria-killing viruses.
The risk of becoming a smoker among young adults who have never smoked is high: 14% will become smokers between the ages of 18 and 24, and three factors predict this behaviour.
Somaxon Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the in-licensing, development and commercialization of proprietary branded pharmaceutical products and late-stage product candidates for the treatment of diseases and disorders in the central nervous system therapeutic area, today announced that the company has received a Complete Response Letter from the U.S. Food and Drug Administration (FDA) for its New Drug Application (NDA) for SilenorĀ® (doxepin) for the treatment of insomnia.
In a Lancet Comment discussing the WHO Global Tuberculosis report 2013 published today [Wednesday 23 October], members of the UK All-Party Parliamentary Group on Global Tuberculosis and lead author Professor Ali Zumla from University College London sound an alarm as the growing threat of multi-drug resistant TB to regional and global health security becomes more apparent.
› Verified 6 days ago